6 March 2021

Diversifying Clinical Trial Inclusion Criteria: Currrent Challenges and Potential Solutions

2021-03-06T10:10:09-08:00

*January 2021* Jill Feldman, co-founder of the EGFR Resisters, presented on Diversifying Clinical Trial Inclusion Criteria: Currrent Challenges and Potential Solutions

Diversifying Clinical Trial Inclusion Criteria: Currrent Challenges and Potential Solutions2021-03-06T10:10:09-08:00
20 December 2019

Project PRIORITY: Why it matters to the EGFR-positive lung cancer community

2019-12-20T23:07:52-08:00

*December 2019* Project PRIORITY (Patient Reported Initiative On Resistance, Incidence, Treatment studY), is a collaboration between LUNGevity Foundation and the EGFR

Project PRIORITY: Why it matters to the EGFR-positive lung cancer community2019-12-20T23:07:52-08:00
Go to Top